tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PBLA Stock Latest News

Panbela Therapeutics Announces Q3 2024 Financial Results
Company AnnouncementsPanbela Therapeutics Announces Q3 2024 Financial Results
1M ago
PBLA
PBLA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PBLA Upcoming Earnings Report: What to Expect?
1M ago
PBLA
Panbela announces first patient enrolled in dose escalation study of CPP-1X-S
PremiumThe Fly
Panbela announces first patient enrolled in dose escalation study of CPP-1X-S
3M ago
PBLA
Is PBLA a Buy, Before Earnings?
PremiumPre-Earnings
Is PBLA a Buy, Before Earnings?
4M ago
PBLA
Panbela Therapeutics says DSMB recommends continuation of ASPIRE trial
PremiumThe Fly
Panbela Therapeutics says DSMB recommends continuation of ASPIRE trial
6M ago
PBLA
Panbela Therapeutics announces oral presentation at Digestive Disease Week
PremiumThe FlyPanbela Therapeutics announces oral presentation at Digestive Disease Week
7M ago
PBLA
Panbela Therapeutics at Risk: Penny Stock Classification May Weaken Legal Safeguards and Hurt Valuation
Premium
Company Announcements
Panbela Therapeutics at Risk: Penny Stock Classification May Weaken Legal Safeguards and Hurt Valuation
7M ago
PBLA
Panbela Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Panbela Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
7M ago
PBLA
PBLA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PBLA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
PBLA
Panbela Therapeutics announces issuance of new patent in US, Canada
PremiumThe Fly
Panbela Therapeutics announces issuance of new patent in US, Canada
8M ago
PBLA
Panbela Therapeutics Updates ASPIRE Trial Timeline
PremiumCompany Announcements
Panbela Therapeutics Updates ASPIRE Trial Timeline
8M ago
8K
PBLA
Panbela announces interim data analysis for ASPIRE trial pushed to Q1 of 2025
PremiumThe Fly
Panbela announces interim data analysis for ASPIRE trial pushed to Q1 of 2025
8M ago
PBLA
Panbela Therapeutics announces poster presentation on ivospemin at AACR
PremiumThe FlyPanbela Therapeutics announces poster presentation on ivospemin at AACR
8M ago
PBLA
Panbela Therapeutics Shifts from Nasdaq to OTCQB Market
Premium
Company Announcements
Panbela Therapeutics Shifts from Nasdaq to OTCQB Market
8M ago
8K
PBLA
Panbela Therapeutics price target lowered to $5 from $16 at H.C. Wainwright
Premium
The Fly
Panbela Therapeutics price target lowered to $5 from $16 at H.C. Wainwright
9M ago
PBLA
Panbela Therapeutics files to sell 255.6K shares of common stock for holders
PremiumThe Fly
Panbela Therapeutics files to sell 255.6K shares of common stock for holders
9M ago
PBLA
Is PBLA a Buy, Before Earnings?
PremiumPre-Earnings
Is PBLA a Buy, Before Earnings?
9M ago
PBLA
Panbela Therapeutics Regains Compliance with Nasdaq Standards
PremiumCompany Announcements
Panbela Therapeutics Regains Compliance with Nasdaq Standards
10M ago
8K
PBLA
Panbela Therapeutics regains compliance with Nasdaq listing standards
PremiumThe Fly
Panbela Therapeutics regains compliance with Nasdaq listing standards
10M ago
PBLA
Roth says NALIPIFOX approval gives investors optimism for Panbela SBP-101 trial
PremiumThe FlyRoth says NALIPIFOX approval gives investors optimism for Panbela SBP-101 trial
10M ago
PBLA
Panbela Therapeutics Issues New Shares Post-Warrant Exercise
Premium
Company Announcements
Panbela Therapeutics Issues New Shares Post-Warrant Exercise
11M ago
8K
PBLA
Panbela Therapeutics Completes Common Stock Offering
Premium
Company Announcements
Panbela Therapeutics Completes Common Stock Offering
11M ago
8K
PBLA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >